The Deal
Sunday, November 22, 
2:36 pm

— Novartis —

Top tags

You have executed a tag search on The Deal Newsweekly. To the right you will find a comprehensive list of stories tagged "Novartis." Below are the most-popular tags for The Deal Newsweekly. On the right of the page you will find a search box to dig deeper into our content.

Community

Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


Regulatory

Of politics and pay

How to fix executive compensation rules without breaking the companies.


Industry Insight

Before the honeymoon ends

Thinking differently about conflict resolution.


Judgment Call

The price of R&D

FAS 141(R): A new source of shareholder litigation against innovation-driven companies?



Entries tagged "Novartis"

The marriage of theory and practice

Abigail Barrow and Steven Shapin on the interaction of science, technology and economic development.


Money, vaccines and lots of soap

Remember the bird flu? Now that another flu strain is threatening the globe, here's a look at where we stand drugwise.


Capital raising 101

Nine alternative measures for life sciences companies to raise funds in today's environment.


Paging Dr. Scholl

The consumer-products subplot in the pharmaceutical megamergers.


The big trial

From VC to licensing, Exelixis has done every kind of deal to keep itself afloat, except one. Is an acquisition next?


Private markets, public health

A new plan hopes FDA vouchers attract big cash and new cures for nasty diseases.


Litigation risk

FASB weighs requiring companies to estimate their exposure to legal damages; business tries to bury the idea.



footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.